tiprankstipranks
Trending News
More News >
Advertisement

EKG - ETF AI Analysis

Compare

Top Page

EKG

First Trust Nasdaq Lux Digital Health Solutions ETF (EKG)

Rating:69Neutral
Price Target:
$20.00
The First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) has a solid overall rating, reflecting its focus on companies with strong financial performance and strategic growth initiatives. Top holdings like IQVIA and Intuitive Surgical contribute positively to the fund's rating due to their robust revenue growth, profitability, and innovative strategies, despite some valuation concerns. However, weaker holdings such as Exact Sciences, which faces profitability challenges, may slightly weigh on the ETF's overall score. A key risk factor is the fund's concentration in healthcare and digital health, which could expose it to sector-specific volatility.
Positive Factors
Strong Top Holdings
Several top positions, such as Veeva Systems and Hims & Hers Health, have delivered strong year-to-date performance, supporting the ETF's overall gains.
Focused Sector Exposure
The ETF's concentration in the health care sector allows investors to benefit from growth in digital health solutions.
Consistent Performance
The fund has shown steady gains across multiple timeframes, including year-to-date, three months, and one month.
Negative Factors
High Sector Concentration
Nearly all assets are allocated to the health care sector, increasing vulnerability to sector-specific risks.
Geographic Over-Concentration
The ETF is heavily focused on U.S. companies, offering little diversification across global markets.
Mixed Holdings Performance
Some top holdings, like Intuitive Surgical and Dexcom, have underperformed year-to-date, potentially dragging on overall returns.

EKG vs. SPDR S&P 500 ETF (SPY)

EKG Summary

The First Trust Nasdaq Lux Digital Health Solutions ETF (ticker: EKG) focuses on companies in the digital health sector, combining technology with health care to improve patient care and medical practices. It includes innovative firms like IQVIA Holdings and Veeva Systems, which are leaders in health care IT and services. This ETF is a great option for investors looking to tap into the growth potential of health care technology and diversify their portfolio with a focus on this dynamic industry. However, new investors should be aware that its performance is heavily tied to the health care sector, which can be sensitive to regulatory changes and market trends.
How much will it cost me?The First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) has an expense ratio of 0.65%, which means you’ll pay $6.50 per year for every $1,000 invested. This is higher than average because it is actively managed, focusing on a niche sector like digital health that requires specialized research and expertise.
What would affect this ETF?The EKG ETF, focused on digital health innovations, could benefit from growing demand for telemedicine, wearable health devices, and AI-driven diagnostics as health care increasingly integrates technology. However, it may face challenges from regulatory changes in health care, economic downturns affecting consumer spending on health tech, or competition within the sector. Its global exposure and top holdings in companies like IQVIA and Veeva Systems position it well for growth but also make it sensitive to international market conditions.

EKG Top 10 Holdings

The EKG ETF is riding the wave of digital health innovation, with strong contributions from Exact Sciences and Natera, both showing bullish momentum thanks to strategic growth and positive earnings calls. Veeva Systems is steady, benefiting from profitability and advancements, though valuation concerns linger. On the flip side, Intuitive Surgical and Dexcom are dragging the fund, with mixed technical indicators and bearish trends dampening their performance. With nearly all holdings rooted in the health care sector and a global focus, the fund is heavily concentrated in cutting-edge health care technologies, making it a bet on the future of medicine.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Intuitive Surgical8.81%$242.12K$194.46B2.11%
78
Outperform
IQVIA Holdings8.41%$231.10K$35.78B-3.82%
77
Outperform
Veeva Systems8.23%$226.27K$48.40B23.92%
81
Outperform
Resmed6.92%$190.23K$35.79B-1.08%
71
Outperform
Dexcom5.86%$161.01K$23.12B-17.07%
69
Neutral
Guardant Health5.07%$139.37K$11.98B236.66%
54
Neutral
Illumina4.61%$126.68K$18.71B-19.84%
73
Outperform
Natera4.48%$123.26K$27.44B48.00%
69
Neutral
Exact Sciences4.41%$121.33K$13.19B30.57%
62
Neutral
Hologic4.20%$115.45K$16.52B-5.85%
69
Neutral

EKG Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
17.77
Positive
100DMA
17.59
Positive
200DMA
17.18
Positive
Market Momentum
MACD
0.21
Positive
RSI
58.30
Neutral
STOCH
48.72
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EKG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 18.22, equal to the 50-day MA of 17.77, and equal to the 200-day MA of 17.18, indicating a bullish trend. The MACD of 0.21 indicates Positive momentum. The RSI at 58.30 is Neutral, neither overbought nor oversold. The STOCH value of 48.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EKG.

EKG Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$2.78M0.65%
69
Neutral
$85.15M0.75%
62
Neutral
$58.04M0.50%
61
Neutral
$50.68M0.50%
65
Neutral
$50.33M0.75%
66
Neutral
$8.37M0.39%
64
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
18.45
0.96
5.49%
CANC
Tema Oncology ETF
FMED
Fidelity Disruptive Medicine ETF
HEAL
Global X HealthTech ETF
HRTS
Tema Cardiovascular and Metabolic ETF
FDHT
Fidelity Digital Health ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement